Sternberg CN - Search Results

1

Adjuvant Pazopanib Versus Placebo After Nephrectomy in Patients With Localized or Locally Advanced Renal Cell Carcinoma: Final Overall Survival Analysis of the Phase 3 PROTECT Trial.

Motzer RJ, Russo P, Haas N, Doehn C, Donskov F, Gross-Goupil M, Varlamov S, Kopyltsov E, Lee JL, Lim HY, Melichar B, Zemanova M, Rini B, Choueiri TK, Wood L, Reaume MN, Stenzl A, Chowdhury S, McDermott R, Michael A, Izquierdo M, Aimone P, Zhang H, Sternberg CN; PROTECT study investigators. Motzer RJ, et al. Among authors: sternberg cn. Eur Urol. 2021 Mar;79(3):334-338. doi: 10.1016/j.eururo.2020.12.029. Epub 2021 Jan 15. Eur Urol. 2021. PMID: 33461782 Free PMC article. Clinical Trial.

2

Phase II trial of trimetrexate in patients with advanced renal cell carcinoma. Clinical Community Oncology Program.

Sternberg CN, Yagoda A, Scher H, Bosl G, Dershaw D, Rosado K, Houston C, Rosenbluth R, Vinciguerra V, Boselli B. Sternberg CN, et al. Eur J Cancer Clin Oncol. 1989 Apr;25(4):753-4. doi: 10.1016/0277-5379(89)90215-0. Eur J Cancer Clin Oncol. 1989. PMID: 2523810 No abstract available.

3

Chemotherapeutic management of invasive bladder carcinoma.

Sternberg CN, Yagoda A, Scher HI, Watson RC, Herr HW, Morse MJ, Sogani PC, Vaughan ED, Bander N, Geller N, et al. Sternberg CN, et al. Eur Urol. 1988;14 Suppl 1:19-20. doi: 10.1159/000473033. Eur Urol. 1988. PMID: 3053199 Clinical Trial. No abstract available.

4

M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for advanced transitional cell carcinoma of the urothelium.

Sternberg CN, Yagoda A, Scher HI, Watson RC, Herr HW, Morse MJ, Sogani PC, Vaughan ED Jr, Bander N, Weiselberg LR, et al. Sternberg CN, et al. J Urol. 1988 Mar;139(3):461-9. doi: 10.1016/s0022-5347(17)42494-3. J Urol. 1988. PMID: 3343727

5

Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) effect on the primary bladder lesion.

Scher HI, Yagoda A, Herr HW, Sternberg CN, Bosl G, Morse MJ, Sogani PC, Watson RC, Dershaw DD, Reuter V, et al. Scher HI, et al. Among authors: sternberg cn. J Urol. 1988 Mar;139(3):470-4. doi: 10.1016/s0022-5347(17)42495-5. J Urol. 1988. PMID: 3343728

6

Neoadjuvant M-VAC (methotrexate, vinblastine, doxorubicin and cisplatin) for extravesical urinary tract tumors.

Scher HI, Yagoda A, Herr HW, Sternberg CN, Morse MJ, Sogani PC, Watson RC, Reuter V, Whitmore WF Jr, Fair WR. Scher HI, et al. Among authors: sternberg cn. J Urol. 1988 Mar;139(3):475-7. doi: 10.1016/s0022-5347(17)42496-7. J Urol. 1988. PMID: 3343729

7

Treatment of brain metastases from bladder cancer.

Rosenstein M, Wallner K, Scher H, Sternberg CN. Rosenstein M, et al. Among authors: sternberg cn. J Urol. 1993 Mar;149(3):480-3. doi: 10.1016/s0022-5347(17)36123-2. J Urol. 1993. PMID: 8437250

8

Long-term follow-up of G3T1 transitional cell carcinoma of the bladder treated with intravesical bacille Calmette-Guérin: 18-year experience.

Pansadoro V, Emiliozzi P, de Paula F, Scarpone P, Pansadoro A, Sternberg CN. Pansadoro V, et al. Among authors: sternberg cn. Urology. 2002 Feb;59(2):227-31. doi: 10.1016/s0090-4295(01)01603-x. Urology. 2002. PMID: 11834391

9

Metastatic renal cell carcinoma: recent advances in the targeted therapy era.

Di Lorenzo G, Autorino R, Sternberg CN. Di Lorenzo G, et al. Among authors: sternberg cn. Eur Urol. 2009 Dec;56(6):959-71. doi: 10.1016/j.eururo.2009.09.002. Epub 2009 Sep 8. Eur Urol. 2009. PMID: 19748725 Review.

10

Pazopanib for the treatment of renal cell carcinoma and other malignancies.

Sonpavde G, Hutson TE, Sternberg CN. Sonpavde G, et al. Among authors: sternberg cn. Drugs Today (Barc). 2009 Sep;45(9):651-61. Drugs Today (Barc). 2009. PMID: 19956806 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

472 results

Search Page

Filters